Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001720580-26-000008
Filing Date
2026-03-12
Accepted
2026-03-12 16:27:42
Documents
103
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K acet-20251231.htm   iXBRL 10-K 3395192
2 EX-3.1 acet-ex3_1.htm EX-3.1 69538
3 EX-4.1 acet-ex4_1.htm EX-4.1 38323
4 EX-10.32 acet-ex10_32.htm EX-10.32 64682
5 EX-23.1 acet-ex23_1.htm EX-23.1 3577
6 EX-31.1 acet-ex31_1.htm EX-31.1 19103
7 EX-31.2 acet-ex31_2.htm EX-31.2 18878
8 EX-32.1 acet-ex32_1.htm EX-32.1 10018
9 GRAPHIC img159393827_0.jpg GRAPHIC 136617
10 GRAPHIC img165055151_0.jpg GRAPHIC 381448
11 GRAPHIC img165055151_1.jpg GRAPHIC 620377
12 GRAPHIC img165055151_2.jpg GRAPHIC 488549
  Complete submission text file 0001720580-26-000008.txt   17944203

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acet-20251231.xsd EX-101.SCH 2386985
106 EXTRACTED XBRL INSTANCE DOCUMENT acet-20251231_htm.xml XML 2360637
Mailing Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116
Business Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1226
Type: 10-K | Act: 34 | File No.: 001-38359 | Film No.: 26748189
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)